Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Neurotox Res. 2020 Jun 30;38(3):808–823. doi: 10.1007/s12640-020-00252-7

Figure 8:

Figure 8:

HPβCD dose dependently suppress SP amplitude. Mean (n=8, shaded area: 95% confidence interval) SP input/output function for the control group at 16, 24, 30 and 45 kHz compared to mean (n=8, +/−SEM) of groups treated with 500, 1000, 2000, 3000 and 4000 mg/kg of HPβCD. SP amplitudes decrease and SP reductions spread to lower frequencies as the dose of HPβCD increases from 1000 to 4000 mg/kg. Residual SP responses still present after treatment with 3000 and 4000 mg/kg of HPβCD.